Late-Breaking Research
Witness First-Time Presentations of Major Clinical Trials and Impactful Science Research
Get a front-row seat to the latest breakthroughs that will change your practice and redefine patient care globally.
Tri-QOL | Pascal M-TEER: Early US Commercial Experience |
EARLY TAVR | TRISCEND II |
Navitor: Early US Commercial Experience | TRILUMINATE |
FOLDAX Mitral Valve Replacement: 1-Year Outcomes | Intrepid TMVR Early Feasibility |
Bronx Valve and TRISPA Registries | DETECT AS |
Global Burden of Disease (GBD) Study | Death on the TAVI Waitlist- French Experience |